Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03853330Completed
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in rib fracture (2 arms), sponsored by Assiut University. Primary endpoint: Verbal Numeric Rating Scale at 24 hours. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03853330.